SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-07-02 09:01
Tx date 2025-07-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		218,298
Filed 2025-06-04 13:07
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$41,922
+8,220 vol
$5.10 each 		215,867
Filed 2025-06-04 13:05
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-41,922
-8,220 vol
$5.10 each 		805,964
Filed 2025-06-04 13:03
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		207,647
Filed 2025-05-19 17:43
Tx date 2025-05-16 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+16,667 vol 		205,216
Filed 2025-05-01 08:55
Tx date 2025-04-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		188,549
Filed 2025-04-03 12:27
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$325,000
+50,000 vol
$6.50 each 		814,184
Filed 2025-04-03 12:21
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$487,500
+75,000 vol
$6.50 each
Filed 2025-04-03 12:18
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		187,507
Filed 2025-03-04 16:50
Tx date 2025-02-28 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		186,465
Filed 2025-02-05 16:49
Tx date 2025-01-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		185,423
Filed 2025-01-06 09:50
Tx date 2025-01-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		184,381
Filed 2024-12-05 17:19
Tx date 2024-12-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		183,339
Filed 2024-11-21 10:34
Tx date 2024-11-18 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$38,749
+15,816 vol
$2.45 each 		182,297
Filed 2024-11-21 10:33
Tx date 2024-11-18 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,749.20
-15,816 vol
$2.45 each 		764,184
Filed 2024-10-04 17:11
Tx date 2024-10-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		166,481
Filed 2024-10-04 17:10
Tx date 2024-10-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
10 - Acquisition or disposition in the public market
+1,042 vol 		2,084
Filed 2024-09-03 17:39
Tx date 2024-09-03 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
+1,042 vol 		165,439
Filed 2024-09-03 17:38
Tx date 2024-09-03 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
10 - Acquisition or disposition in the public market
+1,042 vol 		1,042
Filed 2024-08-02 17:41
Tx date 2024-07-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		164,397
Filed 2024-08-02 17:40
Tx date 2024-07-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
10 - Acquisition or disposition in the public market
-1,042 vol 		0
Filed 2024-08-02 17:38
Tx date 2024-07-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
10 - Acquisition or disposition in the public market
+1,042 vol 		1,042
Filed 2024-07-03 15:10
Tx date 2024-07-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		163,355
Filed 2024-07-03 15:06
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2024-05-21 16:31
Tx date 2024-05-16 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$712,000
+100,000 vol
$7.12 each 		780,000
Filed 2024-05-02 08:30
Tx date 2024-04-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+1,042 vol 		162,313
Filed 2024-04-03 12:16
Tx date 2024-04-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+12,500 vol 		161,271
Filed 2024-04-03 12:13
Tx date 2024-04-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+12,500 vol
Filed 2024-03-29 16:48
Tx date 2024-03-26 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-152,345.6675
-13,975 vol
$10.90 each 		148,771
Filed 2024-03-29 16:47
Tx date 2024-03-25 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-153,690.0625
-13,975 vol
$11.00 each 		162,746
Filed 2023-07-05 16:37
Tx date 2023-06-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-66,150
-7,500 vol
$8.82 each 		176,721
Filed 2023-07-05 16:36
Tx date 2023-06-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-67,275
-7,500 vol
$8.97 each 		184,221
Filed 2023-07-05 16:35
Tx date 2023-06-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-89,900
-10,000 vol
$8.99 each 		191,721
Filed 2023-07-05 16:35
Tx date 2023-06-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$61,250
+25,000 vol
$2.45 each 		201,721
Filed 2023-07-05 16:32
Tx date 2023-06-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-61,250
-25,000 vol
$2.45 each 		680,000
Filed 2023-04-28 16:58
Tx date 2023-04-28 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$624,000
+75,000 vol
$8.32 each 		705,000
Filed 2023-04-04 08:49
Tx date 2023-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$624,083
+75,010 vol
$8.32 each 		630,000
Filed 2022-09-22 11:51
Tx date 2022-09-21 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-162,704.08
-19,052 vol
$8.54 each 		176,721
Filed 2021-12-20 17:53
Tx date 2021-12-20 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+37,500 vol 		195,773
Filed 2021-12-20 17:30
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-20 17:29
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-20 17:27
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-20 17:19
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-20 17:15
Tx date 2021-12-20 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$306,000
+75,000 vol
$4.08 each 		554,990
Filed 2021-06-03 08:45
Tx date 2021-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$753,000
+100,000 vol
$7.53 each 		479,990
Filed 2020-08-17 16:44
Tx date 2020-08-17 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-73,510.54
-12,874 vol
$5.71 each 		158,273
Filed 2020-08-17 16:43
Tx date 2020-08-14 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-220,952
-38,900 vol
$5.68 each 		171,147
Filed 2020-08-17 16:41
Tx date 2020-08-13 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-224,037.56
-38,828 vol
$5.77 each 		210,047
Filed 2020-08-17 16:39
Tx date 2020-08-13 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-599,329.12
-97,136 vol
$6.17 each 		248,875
Filed 2020-08-17 16:38
Tx date 2020-08-13 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$599,327
+323,961 vol
$1.85 each 		346,011
Filed 2020-08-14 08:02
Tx date 2020-08-13 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-764,547.96
-323,961 vol
$2.36 each 		379,990
Filed 2020-05-15 17:47
Tx date 2020-05-15 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$866,250
+125,000 vol
$6.93 each 		703,951
Filed 2019-04-06 09:54
Tx date 2019-04-04 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$386,400
+80,000 vol
$4.83 each 		578,951
Filed 2018-08-17
Tx date 2018-08-15 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-24,552
-17,050 vol
$1.44 each 		498,951
Filed 2018-08-17
Tx date 2018-08-15 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,552
+17,050 vol
$1.44 each 		22,050
Filed 2018-02-07
Tx date 2018-02-06 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$419,000
+50,000 vol
$8.38 each 		516,001
Filed 2017-06-28
Tx date 2017-06-27 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$254,999
+50,000 vol
$5.10 each 		466,001
Filed 2016-07-08
Tx date 2016-07-05 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$183,750
+75,000 vol
$2.45 each 		416,001
Filed 2015-11-19
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		700,000
Filed 2015-11-18
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		341,001
Filed 2015-11-18
Tx date 2015-11-12 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		5,000